Melola Discovery

← Melola Discovery

Journal

Antiproliferative and Apoptosis-Inducing Effects of Iodine Molecule in Differentiated Primary Thyroid Cancer Cells: In Vitro Study

Biosaintifika: Journal of Biology & Biology Education · Vol. 18 No. 1 (2026) · pp. 166–173

DOI
10.15294/biosaintifika.v18i1.42523
ISSN
2338-7610, 2085-191X
Published
2026-04-28
Publisher
Universitas Negeri Semarang
Language
eng

Abstract

Thyroid cancer poses a persistent clinical challenge, particularly when conventional therapies fall short. Growing evidence suggests that molecular iodine (I₂) may exert direct antitumor effects beyond its classical role in thyroid hormone synthesis. This study evaluated the antiproliferative and apoptosis-inducing effects of I₂ on primary cell cultures derived from differentiated thyroid cancer tissue and established dose- and time-response relationships. Primary cultures were exposed to I₂ at concentrations of 5, 10, 20, 40, 80, and 100 µM for 24, 48, and 72 hours. Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, with IC₅₀ calculated accordingly. Apoptosis was characterized by acridine orange/propidium iodide (AO/PI) double-staining, analyzed by fluorescence microscopy and ImageJ software. I₂ demonstrated clear antiproliferative and apoptotic activity in a dose- and time-dependent manner. The strongest effect appeared at 100 µM after 72 hours, reducing viability to 1.39% (p < 0.001). At the IC₅₀ of 2.09 µM, iodine significantly suppressed proliferation and induced apoptosis, with an apoptosis rate of 81.77% ± 12.24% (p = 0.004). These findings confirm the meaningful antineoplastic potential of I₂ against differentiated thyroid cancer cells. This study supports SDG 3 (Good Health and Well-Being), contributing to efforts to develop more equitable, effective cancer treatment options and to reduce cancer-related morbidity globally.

Keywords

Collaboration network of the authors

32 authors · 103 co-authorship links

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Halu Oleo
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Putri ArianiAffiliation unknown1
Dedy KurniaAffiliation unknown1
Rudy AfriantAffiliation unknown1
Rina GustiaAffiliation unknown1
RikarniAffiliation unknown1
Rinal EffendiAffiliation unknown1
Dewi AnggrainiUniversitas Halu Oleo1
Yustinus MaladanAffiliation unknown1
Indra YoviAffiliation unknown1
Dodi SafariAffiliation unknown1
Nur Afrainin SyahAffiliation unknown1
Rosantia SarassariAffiliation unknown1
Ayummi AzzahrahAffiliation unknown1
Nicholas Gilbert PelawiAffiliation unknown1
Tuan Van NguyenAffiliation unknown1
Dodi WijayaAffiliation unknown1
Nurfika AsmaningrumAffiliation unknown1
Kholid Rosyidi Muhammad NurAffiliation unknown1
Hurin'in Aisy BaridahAffiliation unknown1
Made Dian KusumawatiAffiliation unknown1
Irfan WabulaAffiliation unknown1
Hidayat ArifinAffiliation unknown1
Boby Febri KrisdiantoAffiliation unknown1
Mohd. JamilAffiliation unknown1
Leni MerdawatiAffiliation unknown1
Wirsma Arif HarahapAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) https://journal.unnes.ac.id/journals/biosaintifika/oai, first harvested 5 Nov 2026, last seen 8 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Antiproliferative and Apoptosis-Inducing Effects of Iodine Molecule in Differentiated Primary Thyroid Cancer Cells: In Vitro Study</dc:title>
	<dc:creator xml:lang="en">Kurniawati, Yulia</dc:creator>
	<dc:creator xml:lang="en">Atiqah, Jihan</dc:creator>
	<dc:creator xml:lang="en">Meinapuri, Malinda</dc:creator>
	<dc:creator xml:lang="en">Khambri, Daan</dc:creator>
	<dc:creator xml:lang="en">Kartamihardja, Achmad Hussein</dc:creator>
	<dc:creator xml:lang="en">Elliyanti, Aisyah</dc:creator>
	<dc:subject xml:lang="en">Antiproliferative</dc:subject>
	<dc:subject xml:lang="en">Apoptosis</dc:subject>
	<dc:subject xml:lang="en">Differentiated Thyroid Cancer</dc:subject>
	<dc:subject xml:lang="en">Iodine Molecule</dc:subject>
	<dc:subject xml:lang="en">In vitro</dc:subject>
	<dc:description xml:lang="en">Thyroid cancer poses a persistent clinical challenge, particularly when conventional therapies fall short. Growing evidence suggests that molecular iodine (I₂) may exert direct antitumor effects beyond its classical role in thyroid hormone synthesis. This study evaluated the antiproliferative and apoptosis-inducing effects of I₂ on primary cell cultures derived from differentiated thyroid cancer tissue and established dose- and time-response relationships. Primary cultures were exposed to I₂ at concentrations of 5, 10, 20, 40, 80, and 100 µM for 24, 48, and 72 hours. Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, with IC₅₀ calculated accordingly. Apoptosis was characterized by acridine orange/propidium iodide (AO/PI) double-staining, analyzed by fluorescence microscopy and ImageJ software. I₂ demonstrated clear antiproliferative and apoptotic activity in a dose- and time-dependent manner. The strongest effect appeared at 100 µM after 72 hours, reducing viability to 1.39% (p &amp;lt; 0.001). At the IC₅₀ of 2.09 µM, iodine significantly suppressed proliferation and induced apoptosis, with an apoptosis rate of 81.77% ± 12.24% (p = 0.004). These findings confirm the meaningful antineoplastic potential of I₂ against differentiated thyroid cancer cells. This study supports SDG 3 (Good Health and Well-Being), contributing to efforts to develop more equitable, effective cancer treatment options and to reduce cancer-related morbidity globally.</dc:description>
	<dc:publisher xml:lang="en">Universitas Negeri Semarang</dc:publisher>
	<dc:date>2026-04-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://journal.unnes.ac.id/journals/biosaintifika/article/view/42523</dc:identifier>
	<dc:identifier>10.15294/biosaintifika.v18i1.42523</dc:identifier>
	<dc:source xml:lang="en">Biosaintifika: Journal of Biology &amp; Biology Education; Vol. 18 No. 1 (2026): April 2026; 166-173</dc:source>
	<dc:source>2338-7610</dc:source>
	<dc:source>2085-191X</dc:source>
	<dc:source>10.15294/biosaintifika.v18i1</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://journal.unnes.ac.id/journals/biosaintifika/article/view/42523/9704</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2026 Biosaintifika: Journal of Biology &amp; Biology Education</dc:rights>
</oai_dc:dc>